Modeling human gastric cancers in immunocompetent mice

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Gastric cancer (GC) is a leading cause of cancer mortality globally.
• GC exhibits significant heterogeneity, complicating research and therapeutic development.
• Understanding GC's molecular and environmental drivers is critical.

Purpose of the Study:

• To review progress and challenges in gastric cancer research.
• To summarize immunocompetent mouse models for GC studies.
• To highlight the role of mouse models in advancing antitumor immunity and immunotherapy.

Main Methods:

• Review of current scientific literature on gastric cancer.
• Analysis of molecular subtyping and immune microenvironment studies.
• Evaluation of preclinical immunocompetent mouse models and organoid cultures.

Main Results:

• Significant advancements in understanding GC molecular subtypes and immune evasion.
• Development of preclinical models, including immunocompetent mice, aids mechanistic studies.
• Genetically engineered mouse models show promise for immunotherapy research.

Conclusions:

• Addressing GC heterogeneity is key to improving diagnostics and therapeutics.
• Immunocompetent mouse models are invaluable for studying GC antitumor immunity.
• Further research using these models can accelerate the development of novel gastric cancer immunotherapies.